How Novo Nordisk slipped from the front in the GLP1 weight-loss race

AllCourtTENNIS said:

Marketwatch ran a fairly lengthy piece looking at the corporate contest between Novo and Lilly. Since this outlet limits you to 1 free article each month, I've included a pdf as well.


https://www.marketwatch.com/story/how-ozempic-maker-novo-nordisk-blew-its-lead-in-glp-1-weight-loss-drugs-can-europe-compete-in-the-high-stakes-global-economy-0a2bcfd0?mod=home_lead
Wasn't OTP suggesting that with the patent about to lapse they were looking at the compounding market and china, or words to that effect?

View: https://www.youtube.com/watch?v=plGCXR7PmQw&list=PLB_RSqpKtbEHo-3C3MCQTepuAIdG85KLs&index=124
 
Back
Top